Quick Search

 

 


 

 

Result Summary for 113150_1

Result Summary
Protocol ID: 113150_1
Clinical Study ID: WWE113150
Official Title: Prevalence of Known Mutations Associated with HIV Resistance to Protease Inhibitors (PI) among Subjects Failing a First Line Regimen Containing PIs and Subsequent Regimens Containing PIs
Phase: N/A
Study Indications or Diseases:
  • Infection, Human Immunodeficiency Virus
Generic Name: fosamprenavir
Trade/Product Name: Lexiva
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.